The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

A new study published in Engineering has identified enolase 2 (ENO2) as a key factor in the lymphatic metastasis of head and ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck ...

Discover a recent study that has evaluated the risk of poor prognosis and recurrence, alongside risk factor presence in ...

The FDA has approved Tevimbra with chemotherapy for the first-line treatment of unresectable or metastatic ESCC whose tumors express PD-L1.

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal ...

As of December 31, 2024, Fortress’ consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as of September 30, 2024, and $80.9 million as of December 31, 2023, a ...

Skin cancer is the most common form of cancer in the Netherlands. It is also the fastest-rising form of cancer, and the ...

Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated with efficacy, deepening understanding of MOA and ...